Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis

被引:15
作者
Chan, T.
Chen, Z.
Hao, S.
Xu, S.
Yuan, J.
Saxena, A.
Qureshi, M.
Zheng, C.
Xiang, J.
机构
[1] Univ Saskatchewan, Dept Oncol, Res Unit, Saskatchewan Ctr Agcy,Coll Med, Saskatoon, SK S7N 4H4, Canada
[2] Univ Saskatchewan, Coll Med, Dept Immunol, Saskatchewan Ctr Agcy,Res Unit, Saskatoon, SK S7N 4H4, Canada
[3] Univ Saskatchewan, Coll Med, Dept Pathol, Saskatchewan Ctr Agcy,Res Unit, Saskatoon, SK S7N 4H4, Canada
[4] NIDR, Gene Therapy Branch, NIH, Bethesda, MD 20892 USA
基金
加拿大健康研究院;
关键词
HSP70; apoptosis; DC vaccine; antitumor immunity;
D O I
10.1038/sj.cgt.7701025
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The dual role of heat shock protein 70 (HSP70), as antigenic peptide chaperone and danger signal, makes it especially important in dendritic cell (DC)-based vaccination. In this study, we investigated the impacts of apoptotic transgenic MCA/ HSP tumor cells expressing HSP70 on DC maturation, T- cell stimulation and vaccine efficacy. We found that DCs with phagocytosis of MCA/ HSP in early phase of apoptosis expressed more pMHC I complexes, stimulated stronger cytotoxic T lymphocyte (CTL) responses (40% specific killing at an E: T cell ratio of 50) and induced immune protection in 90% of mice against MCA tumor cell challenge, compared with 25% specific CTL killing activity and 60% immune protection seen in mice immunized with DC with phagocytosis of MCA/HSP in late phase of apoptosis (P < 0.05). Similar results were confirmed in another EG7 tumor model also expressing HSP70. Taken together, our data demonstrate that HSP70 on apoptotic tumor cells stimulate DC maturation, and DC with phagocytosis of apoptotic tumor cells expressing HSP70 in early phase of apoptosis more efficiently induced tumor- specific CTL responses and immunity than DCs with phagocytosis of apoptotic tumor cells in late phase of apoptosis. These results may have an important impact in designing DC-based antitumor vaccines. Cancer Gene Therapy (2007) 14, 409 - 420. doi: 10.1038/ sj. cgt. 7701025; published online 19 January 2007.
引用
收藏
页码:409 / 420
页数:12
相关论文
共 61 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[3]   Novel signal transduction pathway utilized by extracellular HSP70 -: Role of Toll-like receptor (TLR) 2 AND TLR4 [J].
Asea, A ;
Rehli, M ;
Kabingu, E ;
Boch, JA ;
Baré, O ;
Auron, PE ;
Stevenson, MA ;
Calderwood, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :15028-15034
[4]   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine [J].
Asea, A ;
Kraeft, SK ;
Kurt-Jones, EA ;
Stevenson, MA ;
Chen, LB ;
Finberg, RW ;
Koo, GC ;
Calderwood, SK .
NATURE MEDICINE, 2000, 6 (04) :435-442
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway [J].
Basu, S ;
Binder, RJ ;
Suto, R ;
Anderson, KM ;
Srivastava, PK .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) :1539-1546
[7]   CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].
Basu, S ;
Binder, RJ ;
Ramalingam, T ;
Srivastava, PK .
IMMUNITY, 2001, 14 (03) :303-313
[8]  
Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
[9]  
2-C
[10]   Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings [J].
Belli, F ;
Testori, A ;
Rivoltini, L ;
Maio, M ;
Andreola, G ;
Sertoli, MR ;
Gallino, G ;
Piris, A ;
Cattelan, A ;
Lazzari, I ;
Carrabba, M ;
Scita, G ;
Santantonio, C ;
Pilla, L ;
Tragni, G ;
Lombardo, C ;
Arienti, F ;
Marchianò, A ;
Queirolo, P ;
Bertolini, F ;
Cova, A ;
Lamaj, E ;
Ascani, L ;
Camerini, R ;
Corsi, M ;
Cascinelli, N ;
Lewis, JJ ;
Srivastava, P ;
Parmiani, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4169-4180